Form 8-K - Current report:
SEC Accession No. 0001193125-15-262003
Filing Date
2015-07-24
Accepted
2015-07-24 08:00:33
Documents
4
Period of Report
2015-07-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d50939d8k.htm 8-K 21333
2 EXHIBIT 4.1 d50939dex41.htm EX-4.1 21920
3 EXHIBIT 4.2 d50939dex42.htm EX-4.2 30733
4 EXHIBIT 10.1 d50939dex101.htm EX-10.1 98555
  Complete submission text file 0001193125-15-262003.txt   174058
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: CO | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-53121 | Film No.: 151003441
SIC: 2834 Pharmaceutical Preparations